Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

681
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
681
pre-mRNA Processing02:01

pre-mRNA Processing

57.4K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.4K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

632
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
632
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

868
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
868
Pre-mRNA Processing: Modification of pre-mRNA Ends01:35

Pre-mRNA Processing: Modification of pre-mRNA Ends

14.8K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
14.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming Preeclampsia Care: Molecular Diagnostics and Therapeutic Innovations.

Journal of the American Society of Nephrology : JASN·2026
Same author

The role of supraoptic hypothalamic arginine vasopressin neurons in aging-associated water balance and thermoregulatory deficits in male mice.

Nature communications·2026
Same author

Placental nicotinamide adenine dinucleotide modulates the timing of labor.

Science (New York, N.Y.)·2026
Same author

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Nature medicine·2026
Same author

Butyrophilin 2A2 promotes T cell immunoregulation via CD45 phosphatase activation and protects against murine autoimmune glomerulonephritis and pregnancy loss.

Nature communications·2026
Same author

Pointing Care for Preeclampsia in the Right Direction.

Hypertension (Dallas, Tex. : 1979)·2025

Related Experiment Video

Updated: Jan 28, 2026

Diagnostic Ultrasound Imaging of Mouse Diaphragm Function
07:12

Diagnostic Ultrasound Imaging of Mouse Diaphragm Function

Published on: April 21, 2014

16.6K

Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Elizabeth A Phipps1,2, Ravi Thadhani2,3, Thomas Benzing4

  • 1Nephrology Division, Brigham and Women's Hospital, Boston, MA, USA.

Nature Reviews. Nephrology
|February 23, 2019
PubMed
Summary
This summary is machine-generated.

Pre-eclampsia, a pregnancy complication, involves hypertension and can cause organ dysfunction. Novel antiangiogenic pathways offer insights into its pathophysiology and potential therapeutic strategies.

More Related Videos

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

11.1K
Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

9.7K

Related Experiment Videos

Last Updated: Jan 28, 2026

Diagnostic Ultrasound Imaging of Mouse Diaphragm Function
07:12

Diagnostic Ultrasound Imaging of Mouse Diaphragm Function

Published on: April 21, 2014

16.6K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

11.1K
Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

9.7K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Cardiovascular Research

Background:

  • Pre-eclampsia is a serious pregnancy complication characterized by new-onset hypertension and potential proteinuria.
  • It leads to significant maternal and fetal morbidity and mortality, with risks of multi-organ dysfunction.
  • Maternal endothelial dysfunction, driven by placental factors, is a key feature of pre-eclampsia.

Purpose of the Study:

  • To review the pathogenic role of placental antiangiogenic proteins in pre-eclampsia development.
  • To discuss novel therapeutic strategies targeting angiogenic imbalance in pre-eclampsia.
  • To highlight advances in understanding long-term maternal and fetal risks associated with pre-eclampsia.

Main Methods:

  • Review of current literature on pre-eclampsia pathophysiology.
  • Analysis of research on antiangiogenic pathways and their role in pregnancy complications.
  • Synthesis of findings on predictive markers and therapeutic interventions.

Main Results:

  • Antiangiogenic proteins released by the placenta play a crucial role in pre-eclampsia pathogenesis.
  • Novel therapeutic strategies aim to restore angiogenic balance, offering potential treatment avenues.
  • Pre-eclampsia confers long-term health risks for both mothers and their offspring.

Conclusions:

  • Understanding antiangiogenic pathways is critical for diagnosing and treating pre-eclampsia.
  • Targeted therapies hold promise for mitigating the severe consequences of pre-eclampsia.
  • Long-term monitoring and management are essential for individuals affected by pre-eclampsia.